Apelt et al., 2020 - Google Patents
ERCC1 mutations impede DNA damage repair and cause liver and kidney dysfunction in patientsApelt et al., 2020
View HTML- Document ID
- 2754766675187808458
- Author
- Apelt K
- White S
- Kim H
- Yeo J
- Kragten A
- Wondergem A
- Rooimans M
- González-Prieto R
- Wiegant W
- Lunke S
- Flanagan D
- Pantaleo S
- Quinlan C
- Hardikar W
- van Attikum H
- Vertegaal A
- Wilson B
- Wolthuis R
- Schärer O
- Luijsterburg M
- Publication year
- Publication venue
- Journal of Experimental Medicine
External Links
Snippet
ERCC1-XPF is a multifunctional endonuclease involved in nucleotide excision repair (NER), interstrand cross-link (ICL) repair, and DNA double-strand break (DSB) repair. Only two patients with bi-allelic ERCC1 mutations have been reported, both of whom had features of …
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Volkman et al. | Tight nuclear tethering of cGAS is essential for preventing autoreactivity | |
Canny et al. | Inhibition of 53BP1 favors homology-dependent DNA repair and increases CRISPR–Cas9 genome-editing efficiency | |
Apelt et al. | ERCC1 mutations impede DNA damage repair and cause liver and kidney dysfunction in patients | |
Estey et al. | Distinct roles of septins in cytokinesis: SEPT9 mediates midbody abscission | |
Noordermeer et al. | The shieldin complex mediates 53BP1-dependent DNA repair | |
Hustedt et al. | Control of homologous recombination by the HROB–MCM8–MCM9 pathway | |
Liu et al. | Systematic comparison of 2A peptides for cloning multi-genes in a polycistronic vector | |
Zhang et al. | The microprotein Minion controls cell fusion and muscle formation | |
Nielsen et al. | PICH promotes sister chromatid disjunction and co-operates with topoisomerase II in mitosis | |
Fang et al. | The NEK1 interactor, C21ORF2, is required for efficient DNA damage repair | |
Lafranchi et al. | APC/CC dh1 controls Ct IP stability during the cell cycle and in response to DNA damage | |
Bergink et al. | Recognition of DNA damage by XPC coincides with disruption of the XPC–RAD23 complex | |
Beli et al. | Proteomic investigations reveal a role for RNA processing factor THRAP3 in the DNA damage response | |
Shipman et al. | Functional dependence of neuroligin on a new non-PDZ intracellular domain | |
Yabut et al. | Dyrk1A overexpression inhibits proliferation and induces premature neuronal differentiation of neural progenitor cells | |
Jang et al. | Differential role for phosphorylation in alternative polyadenylation function versus nuclear import of SR-like protein CPSF6 | |
Park et al. | ATAD5 promotes replication restart by regulating RAD51 and PCNA in response to replication stress | |
Mackenzie et al. | Regulation of the divalent metal ion transporter via membrane budding | |
Masuda et al. | TRIM29 regulates the assembly of DNA repair proteins into damaged chromatin | |
Sánchez et al. | Cyclic expression of the voltage‐gated potassium channel KV10. 1 promotes disassembly of the primary cilium | |
Sharp et al. | Cell division requires RNA eviction from condensing chromosomes | |
Krastev et al. | Coupling bimolecular PARylation biosensors with genetic screens to identify PARylation targets | |
Yin et al. | Imaging of mRNA–protein interactions in live cells using novel mCherry trimolecular fluorescence complementation systems | |
Achuthankutty et al. | Regulation of ETAA1-mediated ATR activation couples DNA replication fidelity and genome stability | |
Culver et al. | Huntington’s disease protein huntingtin associates with its own mRNA |